Intensive therapies of vasospasm in patients with aSAH
Total (N = 392) | Period 1 (n = 160)a | Period 2 (n = 232)a | P Value | |
---|---|---|---|---|
Intensive treatment of vasospasm (No.) (%) | 155 (40%) | 47 (29%) | 108 (46%) | <.001 |
Angioplasty (No.) (%) | 145 (37%) | 44 (27%) | 101 (43%) | .001 |
Distal angioplasty (No.) (%)b | 109 (28%) | 35 (22%) | 74 (32%) | .029 |
Distal balloon angioplasty (No.) (%)c | 87 (22%) | 13 (8%) | 74 (32%) | <.001 |
Proximal balloon angioplasty (No.) (%)d | 91 (23%) | 26 (16%) | 65 (28%) | .004 |
Chemical angioplasty (No.) (%)d | 36 (9%) | 31 (19%) | 5 (2%) | <.001 |
Intravenous milrinone (No.) (%) | 86 (22%) | 15 (9%) | 71 (31%) | <.001 |